Overlap syndromes are distinct blood cancers that present with features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN).

Chic Awearness, in collaboration with the Vanderbilt-Ingram Cancer Center, will host a virtual event on Sept. 24 focusing on ovarian cancer research and its impact during COVID-19.

An international group of researchers including Vanderbilt epidemiologists has identified new DNA methylation biomarkers associated with prostate cancer risk.

Vanderbilt-Ingram Cancer Center at Wilson County is slated to open Aug. 31 with a full array of highly specialized services, including diagnostic assessments, medical oncology and radiation oncology.

Sam Chang, MD, MBA, has been named chief surgical officer at Vanderbilt-Ingram Cancer Center (VICC), a new leadership position responsible for advancing excellence in surgical care in cancer patients, expanding service locations, maximizing resource efficiencies and maintaining high-quality standards among other duties.

Combining two drugs reduced colorectal cancer cell growth in vitro and in an animal model, suggesting the combination may be a promising treatment for patients.

Vanderbilt scientists have discovered a new target for normalizing tumor blood vessels to improve cancer immunotherapies.